Login Register
English
0

Cart

$ 0

Genetically engineered nanovesicles based anti-EphA2/CD3 bispecific antibody promotes T cell immune response for triple negative breast cancer treatment(KTB1410-13.2)

Date:2026-03-03 Views:27